How to Help Your Patients Save Money on Pred-G: A Provider's Guide to Savings Programs

Pred-G retails for $160–$190 for a 5 mL bottle without insurance coverage — a meaningful cost for many patients, particularly those on fixed incomes, those with Medicare or Medicaid, or those whose plans don't cover it well. For ophthalmologists and optometrists who routinely prescribe Pred-G for post-surgical care or inflammatory eye disease, having a systematic approach to patient cost management is both good clinical practice and an important part of care coordination. This guide covers every cost-reduction tool available in 2026.

Understanding the Pred-G Cost Landscape

The core cost problem with Pred-G is structural: it is a brand-name-only product with no widely available AB-rated generic. This keeps prices high and limits patients' cost-reduction options. By contrast, competing products like Tobradex have robust generic markets — generic tobramycin/dexamethasone costs patients $28–$55 with a discount card. Understanding this gap helps frame conversations with patients about both cost and alternatives.

Key price reference points for 2026:

• Pred-G retail (no insurance): $160–$190 for 5 mL suspension
• Pred-G with GoodRx/discount card: Approximately $161–$172 at participating pharmacies
• Commercial insurance copay (Tier 2–3): Typically $15–$60
• Generic Tobradex (clinical alternative): $28–$55 with discount card
• Generic Maxitrol (clinical alternative): $15–$40 with discount card

Tool 1: Prescription Discount Cards

Prescription discount programs — GoodRx, SingleCare, RxSaver, Blink Health — provide a modest but immediate reduction off the retail price of Pred-G. The best discount available varies by pharmacy and location. GoodRx typically shows prices in the $161–$172 range for Pred-G suspension.

Practical provider tip: Include the GoodRx.com URL and instructions in your post-visit summary or discharge instructions, especially for uninsured or underinsured patients. A brief mention at the point of prescribing — "this medication can be expensive; check GoodRx for the best price at pharmacies near you" — sets expectations and provides actionable guidance.

Tool 2: Allergan/AbbVie Patient Assistance Programs

Allergan (now AbbVie) operates patient assistance programs that may provide Pred-G at no cost or reduced cost to qualifying patients. Eligibility criteria typically include income thresholds and lack of adequate insurance coverage for the medication.

For your practice, having a designated staff member or office manager maintain awareness of current Allergan assistance offerings can facilitate patient enrollment. Resources to check:

• myAbbVie Assist: AbbVie's patient assistance program (myabbvieassist.com)
• NeedyMeds.org: Maintains a comprehensive listing of manufacturer assistance programs including Allergan products
• RxAssist.org: Another aggregator of pharmaceutical manufacturer patient assistance programs

Tool 3: Insurance Prior Authorization and Formulary Exceptions

Many commercial insurance plans and Medicare Advantage plans place Pred-G on Tier 2 or Tier 3 of their formulary. Some require prior authorization (PA) before covering it, particularly if a lower-cost alternative (like generic tobramycin/dexamethasone) is on the formulary.

Provider action items:

• Submit PA promptly: If a patient's insurance requires PA, submit with complete clinical documentation — diagnosis, prior treatment history, and medical necessity rationale for Pred-G specifically (e.g., the prednisolone 1% potency is required; why the alternative is clinically inferior for this patient).
• Provide a bridge prescription: For post-operative patients who cannot wait for PA approval, consider writing a bridge prescription for a lower-cost covered alternative to bridge until the PA is resolved, or provide samples from your office to prevent treatment gaps.
• Request formulary exceptions: If a plan doesn't cover Pred-G at all, a formulary exception request with clinical documentation of why cheaper alternatives are inadequate for the specific patient may secure coverage.

Tool 4: Prescribing Clinically Equivalent Generics When Appropriate

The most powerful cost-reduction tool available is a clinical decision: for patients in whom generic tobramycin/dexamethasone or generic neomycin/polymyxin B/dexamethasone (Maxitrol) is clinically equivalent, prescribing the generic alternative reduces cost by 65–85% compared to brand Pred-G.

Consider documenting your decision rationale in the chart when you choose Pred-G over generic alternatives — this supports PA submissions and demonstrates medical necessity if questioned by the payer. When generic alternatives are clinically acceptable, prescribing them by default (with the option to switch if needed) is a patient-centered approach to cost management.

Tool 5: Office Dispensing for Immediate Post-Surgical Patients

In-office dispensing of post-operative medications to surgical patients at the point of care can reduce both the access problem and the cost problem simultaneously. When practices dispense Pred-G at the time of surgery, they can price it competitively and eliminate the pharmacy markup. Check state regulations for in-office dispensing requirements before implementing.

Communicating Cost Proactively With Patients

Patients are more likely to adhere to treatment when cost barriers are addressed proactively. Brief language at the point of prescribing — mentioning the expected cost range, the GoodRx option, and availability of assistance programs — sets expectations and prevents patients from not filling the prescription due to sticker shock. For patients who struggle with both cost and availability, medfinder can help locate the most accessible and affordable pharmacy option in their area.

Summary

Managing Pred-G cost for your patients involves a layered approach: discount cards for uninsured patients, PA submission for insured patients, patient assistance for low-income patients, in-office dispensing for surgical patients, and — where clinically appropriate — a switch to a lower-cost generic alternative. For a patient-facing version of this information, see our patient guide to saving on Pred-G.